AC
BLTE

Armistice Capital’s Belite Bio BLTE Stock Holding History

Armistice Capital’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-167,930
Closed -$10.6M – 235
2024
Q4 		$10.6M Buy
+167,930
New +$11.1M 0.25% 89
2024
Q3 		– Sell
-148,000
Closed -$6.76M – 263
2024
Q2 		$6.76M Buy
+148,000
New +$6.41M 0.18% 102
2024
Q1 		– Sell
-36,000
Closed -$1.65M – 348
2023
Q4 		$1.65M Buy
+36,000
New +$1.38M 0.04% 160
2023
Q3 		– Sell
-210,915
Closed -$3.01M – 256
2023
Q2 		$3.01M Buy
+210,915
New +$4.79M 0.08% 131

Other funds holding BLTE

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.3B AUM 33.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
HF
HRT Financial New York $26B AUM 58.22% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return
VIA
Virtus Investment Advisers Hartford, Connecticut $363M AUM 34.89% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return